Metformin Suppresses Cancer Stem Cells through AMPK Activation and Inhibition of Protein Prenylation of the Mevalonate Pathway in Colorectal Cancer
出版年份 2020 全文链接
标题
Metformin Suppresses Cancer Stem Cells through AMPK Activation and Inhibition of Protein Prenylation of the Mevalonate Pathway in Colorectal Cancer
作者
关键词
-
出版物
Cancers
Volume 12, Issue 9, Pages 2554
出版商
MDPI AG
发表日期
2020-09-08
DOI
10.3390/cancers12092554
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Metformin exhibited anticancer activity by lowering cellular cholesterol content in breast cancer cells
- (2019) Ankit Sharma et al. PLoS One
- Metastatic Colorectal Cancer: Prognostic And Predictive Factors
- (2019) Anna Nappi et al. CURRENT MEDICINAL CHEMISTRY
- Effects of metformin on colorectal cancer stem cells depend on alterations in glutamine metabolism
- (2018) Jae Hyun Kim et al. Scientific Reports
- Is cholesterol a mediator of cold-induced cancer?
- (2016) Chandi C. Mandal et al. TUMOR BIOLOGY
- Metformin suppressed the proliferation of LoVo cells and induced a time-dependent metabolic and transcriptional alteration
- (2015) Jiaojiao He et al. Scientific Reports
- Targeting cancer stem cells by curcumin and clinical applications
- (2014) Yanyan Li et al. CANCER LETTERS
- Role of Oncogenic K-Ras in Cancer Stem Cell Activation by Aberrant Wnt/β-Catenin Signaling
- (2014) Byoung-San Moon et al. JNCI-Journal of the National Cancer Institute
- Synergistic Simvastatin and Metformin Combination Chemotherapy for Osseous Metastatic Castration-Resistant Prostate Cancer
- (2014) M. A. Babcook et al. MOLECULAR CANCER THERAPEUTICS
- IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples
- (2014) Frency Varghese et al. PLoS One
- Chemopreventive drugs: Mechanismsviainhibition of cancer stem cells in colorectal cancer
- (2014) Tae Il Kim WORLD JOURNAL OF GASTROENTEROLOGY
- Metformin-Induced Killing of Triple-Negative Breast Cancer Cells Is Mediated by Reduction in Fatty Acid Synthase via miRNA-193b
- (2014) Reema S. Wahdan-Alaswad et al. Hormones & Cancer
- Metabolic roles of AMPK and metformin in cancer cells
- (2013) Yeon Kyung Choi et al. MOLECULES AND CELLS
- Induction of the Stem-like Cell Regulator CD44 by Rho Kinase Inhibition Contributes to the Maintenance of Colon Cancer-Initiating Cells
- (2012) H. Ohata et al. CANCER RESEARCH
- Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
- (2012) William A. Freed-Pastor et al. CELL
- Novel Aspects of Mevalonate Pathway Inhibitors as Antitumor Agents
- (2012) M. Thurnher et al. CLINICAL CANCER RESEARCH
- Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer
- (2012) Jin Ha Lee et al. DIGESTIVE AND LIVER DISEASE
- Targeting tumor cell metabolism with statins
- (2012) J W Clendening et al. ONCOGENE
- AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
- (2011) Yu Li et al. Cell Metabolism
- Metformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth
- (2011) G. Z. Rocha et al. CLINICAL CANCER RESEARCH
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Rho GTPases in cancer cell biology
- (2008) Francisco M. Vega et al. FEBS LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started